ChemChina-Syngenta Deal Faces Investor Concern

(Beijing) — Investors are expressing concern that ChemChina’s proposed $43 billion acquisition of Swiss agribusiness giant Syngenta has run up against new challenges.

The current financing structure, based on interviews with people close to the negotiations, as well as private documents Caixin has seen, indicate uncertainties over who will provide an important piece of funding to the tune of $15 billion, upon which the remainder of funds needed for ChemChina to acquire all Syngenta shares depends.